| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIO-TECHNE Corp | President-Protein Sciences | Common Stock | 2.12K | $164K | $77.42 | Nov 16, 2021 | Direct |
| BIO-TECHNE Corp | President-Protein Sciences | Restricted Stock Units | 1.56K | $125K | $80.32 | Nov 12, 2021 | Direct |
| Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 30K | Feb 12, 2025 | Direct | ||
| BIO-TECHNE Corp | President-Protein Sciences | Stock Options (Right to Buy) | 0 | Nov 16, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | Feb 12, 2025 | 1 | $0 | 4 | Feb 14, 2025 | Director |
| MRKR | Marker Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| TECH | BIO-TECHNE Corp | Nov 12, 2021 | 14 | -$10.2M | 4 | Nov 16, 2021 | President-Protein Sciences |
| TECH | BIO-TECHNE Corp | Aug 31, 2021 | 1 | -$774K | 4 | Sep 2, 2021 | President-Protein Sciences |
| TECH | BIO-TECHNE Corp | Aug 6, 2021 | 6 | -$481K | 4 | Aug 10, 2021 | President-Protein Sciences |
| MRKR | Marker Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| MRKR | Marker Therapeutics, Inc. | Mar 16, 2021 | 5 | $250K | 4 | Jun 8, 2023 | Director |